Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

Recruiting

Phase 2

XylitolXylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant

Sponsor:

Children's Hospital Medical Center, Cincinnati

Code:

NCT05579639

Conditions

Allogeneic Stem Cell Transplantation

Eligibility Criteria

Sex: All

Age: 4 - 25

Healthy Volunteers: Not accepted

Interventions

Xylitol

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Children's Hospital Medical Center, Cincinnati on 2025-03-07.